Thioridazine inhibits angiogenesis and tumor growth by targeting the VEGFR-2/PI3K/mTOR pathway in ovarian cancer xenografts.
Thioridazine inhibits angiogenesis and tumor growth by targeting the VEGFR-2/PI3K/mTOR pathway in ovarian cancer xenografts.
复制标题
DOI:
10.18632/oncotarget.2063
复制
发表时间:
2014-07-15
期刊:
影响因子:
--
通讯作者:
Rho SB
中科院分区:
文献类型:
--
作者:
Park MS;Dong SM;Kim BR;Seo SH;Kang S;Lee EJ;Lee SH;Rho SB
Thioridazine, a member of the phenothiazine family, is a powerful anti-anxiety and anti-psychotic drug. It can also suppress the growth of several types of tumor in vitro. In the current study, we evaluated the direct anti-tumor and anti-angiogenic effects of thioridazine in vivo. The injection of thioridazine into human ovarian tumor xenografts in nude mice significantly inhibited tumor growth by ~fivefold, and also decreased tumor vascularity. In addition, thioridazine inhibited the phosphorylation of the signaling molecules downstream of phosphatidylinositol-3’-kinase (PI3K), including Akt, phosphoinositide-dependent protein kinase 1 (PDK1), and mammalian target of rapamycin (mTOR), during ovarian tumor progression via vascular endothelial growth factor receptor 2 (VEGFR-2). These results provide convincing evidence that thioridazine regulates endothelial cell function and subsequent angiogenesis by inhibiting VEGFR-2/PI3K/mTOR signal transduction. Collectively, these results strongly suggest that thioridazine might be a novel anti-tumor and anti-angiogenic agent for use in ovarian cancer.
登录
查看更多内容
影响因子:
2.7
作者:
Pantazaki, AA;Lialiaris, TS
通讯作者:
Lialiaris, TS
影响因子:
3.1
作者:
Byun, Hyun-Jung;Lee, Jeong Heon;Rho, Seung Bae
通讯作者:
Rho, Seung Bae
影响因子:
5.6
作者:
Xia, Chang;Meng, Qiao;Jiang, Bing-Hua
通讯作者:
Jiang, Bing-Hua
影响因子:
64.8
作者:
Risau, W
通讯作者:
Risau, W
DOI:
10.1016/j.bbapap.2007.09.008
发表时间:
2008-01-01
影响因子:
3.2
作者:
Jiang, Bing-Hua;Liu, Ling-Zhi
通讯作者:
Liu, Ling-Zhi